Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2018.0276


Genome analysis for the development of novel gastric cancer biomarkers.

Prof. Theodore Liakakos, MD, PhD.

Affiliation:Theodore Liakakos, MD, Professor of Surgery, Head of 1st Department of Surgery, National Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.


Despite standardization of D2 gastrectomy plus chemotherapy for resectable gastric cancer recurrence rates, particularly in the West, remain high. Development of predictive biomarkers is considered as a high research priority.
In this special report, potential and challenges of whole-genome sequencing in clinical samples are discussed.

(Citation: Gastric & Breast Cancer 2018; 13(1): 49-54)



You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 31 March 2018